Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. The company announced several positive developments in its fiscal second quarter 2025 business update. It announced the commercial launch of VYKAT XR during the quarter, which is the first FDA-approved treatment for hyperphagia in Prader-Willi Syndrome. Management noted that since the approval, the company has received 646 patient start forms from 295 unique prescribers, covering over 1 ...